European Union Approves Glaxo Bird Flu Vaccine

May 19, 2008

The European Union has approved GlaxoSmithKline's bird flu vaccine Prepandrix.  The vaccine will be used in the event that the H5N1 bird flu virus mutates into a form that is easily transmitted from one human to another..Boston (ChattahBox) – The European Union has approved GlaxoSmithKline’s bird flu vaccine Prepandrix. The vaccine will be used in the event that the H5N1 bird flu virus mutates into a form that is easily transmitted from one human to another.

The vaccine from Glaxo has received approval from the United States, among other countries.

European Union members will now begin to also stock up on the bird flu vaccine as a precautionary measure.

Glaxo is not alone, as Sanofi-Aventis and Novartis are both hard at work on their own bird flu vaccines.

This is the first vaccine of this kind to receive a license from the European Union.

Glaxo has stated that studies have shown their bird flu vaccine to be highly effective against multiple strains.

The H5N1 bird flu virus was first noted back in 2003, and since then has caused many scares around the world.


Comments

Got something to say? **Please Note** - Comments may be edited for clarity or obscenity, and all comments are published at the discretion of ChattahBox.com - Comments are the opinions of the individuals leaving them, and not of ChattahBox.com or its partners. - Please do not spam or submit comments that use copyright materials, hearsay or are based on reports where the supposed fact or quote is not a matter of public knowledge are also not permitted.